Cargando…

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Influenza poses a severe threat to global health. Despite the whole inactivated virus (WIV)‐based nasal vaccine being a promising strategy for influenza protection, the mucosal barrier is still a bottleneck of the nasal vaccine. Here, a catalytic mucosal adjuvant strategy for an influenza WIV nasal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Tao, Ma, Shang, Miao, Xinyu, Tang, Yan, Huangfu, Dandan, Wang, Jinyuan, Jiang, Jing, Xu, Nuo, Yin, Yuncong, Chen, Sujuan, Liu, Xiufan, Yin, Yinyan, Peng, Daxin, Gao, Lizeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509716/ https://www.ncbi.nlm.nih.gov/pubmed/32999833 http://dx.doi.org/10.1002/advs.202000771

Ejemplares similares

PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence
por: Qin, Tao, et al.
Publicado: (2022)

Catalytic inactivation of influenza virus by iron oxide nanozyme
por: Qin, Tao, et al.
Publicado: (2019)

PA-X protein of H9N2 subtype avian influenza virus suppresses the innate immunity of chicken bone marrow-derived dendritic cells
por: Qin, Tao, et al.
Publicado: (2022)

Bidirectionally Regulating Viral and Cellular Ferroptosis with Metastable Iron Sulfide Against Influenza Virus
por: Miao, Xinyu, et al.
Publicado: (2023)

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yin, Yinyan, et al.
Publicado: (2021)

Generation of an avian influenza DIVA vaccine with a H3-peptide replacement located at HA2 against both highly and low pathogenic H7N9 virus
por: Li, Gang, et al.
Publicado: (2022)

Emerging of H5N6 Subtype Influenza Virus with 129-Glycosylation Site on Hemagglutinin in Poultry in China Acquires Immune Pressure Adaption
por: Xu, Nuo, et al.
Publicado: (2022)

Characterization of an H7N9 Influenza Virus Isolated from Camels in Inner Mongolia, China
por: Yin, Yuncong, et al.
Publicado: (2023)

Glycosylation at 11Asn on hemagglutinin of H5N1 influenza virus contributes to its biological characteristics
por: Yin, Yuncong, et al.
Publicado: (2017)

Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks
por: Chen, Sujuan, et al.
Publicado: (2020)

The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling
por: Yang, Hui, et al.
Publicado: (2022)

Synergistic effect of PB2 283M and 526R contributes to enhanced virulence of H5N8 influenza viruses in mice
por: Wang, Xiao, et al.
Publicado: (2017)

Development of a multiplex probe combination-based one-step real-time reverse transcription-PCR for NA subtype typing of avian influenza virus
por: Sun, Zhihao, et al.
Publicado: (2017)

Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses
por: Chen, Sujuan, et al.
Publicado: (2017)

The emergence of new antigen branches of H9N2 avian influenza virus in China due to antigenic drift on hemagglutinin through antibody escape at immunodominant sites
por: Zhang, Nan, et al.
Publicado: (2023)

Identification of a universal antigen epitope of influenza A virus using peptide microarray
por: Wang, Qiuxia, et al.
Publicado: (2021)

Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses
por: Sun, Zhihao, et al.
Publicado: (2018)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice
por: Yang, Hui, et al.
Publicado: (2023)

Genome Sequence of a Novel H10N9 Avian Influenza Virus Isolated from Chickens in a Live Poultry Market in Eastern China
por: Su, Chunhu, et al.
Publicado: (2013)

Influenza a virus antagonizes type I and type II interferon responses via SOCS1-dependent ubiquitination and degradation of JAK1
por: Du, Yinping, et al.
Publicado: (2020)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

A 20-Amino-Acid Deletion in the Neuraminidase Stalk and a Five-Amino-Acid Deletion in the NS1 Protein Both Contribute to the Pathogenicity of H5N1 Avian Influenza Viruses in Mallard Ducks
por: Li, Yanfang, et al.
Publicado: (2014)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

Mucosal Immunization and Adjuvants
por: Hasegawa, Hideki, et al.
Publicado: (2014)

Recombinant Fowlpox Virus Expressing gB Gene from Predominantly Epidemic Infectious Larygnotracheitis Virus Strain Demonstrates Better Immune Protection in SPF Chickens
por: Chen, Sujuan, et al.
Publicado: (2020)

Multiplex one-step Real-time PCR by Taqman-MGB method for rapid detection of pan and H5 subtype avian influenza viruses
por: Zhang, Zhujun, et al.
Publicado: (2017)

Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses
por: Wu, Peipei, et al.
Publicado: (2017)

N-linked glycosylation at site 158 of the HA protein of H5N6 highly pathogenic avian influenza virus is important for viral biological properties and host immune responses
por: Gao, Ruyi, et al.
Publicado: (2021)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction
por: Yin, Yinyan, et al.
Publicado: (2021)

Selective Catalytic Isomerization of β‐Pinene Oxide to Perillyl Alcohol Enhanced by Protic Tetraimidazolium Nitrate
por: Li, Hui, et al.
Publicado: (2021)

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice
por: Ebensen, Thomas, et al.
Publicado: (2017)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
por: Hinkula, Jorma, et al.
Publicado: (2019)

Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control
por: Yin, Yinyan, et al.
Publicado: (2021)

Photodynamic Effect of Hypericin on the Conformation and Catalytic Activity of Hemoglobin
por: Zhao, Jing, et al.
Publicado: (2008)

Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses
por: Hu, Jiao, et al.
Publicado: (2021)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctlufo7e28bg10cppvtos51i5m